Bayban’s Colgate-Palmolive CL Stock Holding History

Bayban’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.8K	Hold	260	–	–	0.02%	316
2026 Q1	$22.2K	Hold	260	–	–	0.02%	329
2025 Q4	$20.5K	Buy	+260	New	+$20.4K	0.02%	332

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bayban's CL Position: Q2 2026 in Review

Bayban held its Colgate-Palmolive (CL) position steady in Q2 2026 at 260 shares worth $23.8K. The position accounts for 0.02% of the portfolio, ranked #316.

Bayban first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 1,923 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Bayban held 260 shares of Colgate-Palmolive worth $23.8K as of Q2 2026.
Bayban left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.02% of Bayban's portfolio in Q2 2026, its #316 holding.
Bayban first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
1,923 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.